Drug intelligence / Profile preview

L-Zinex Duo

Development stage
Phase 1
Lead developer
Iberica Verheilen Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

L-Zinex Duo is a combination oral syrup containing levocetirizine dihydrochloride and montelukast sodium. Developed and marketed by Iberica Verheilen Pharmaceuticals, it is designed to provide dual-action relief for allergic and respiratory conditions. Levocetirizine is a second-generation H1-receptor antagonist that blocks the action of histamine, thereby reducing symptoms such as sneezing, rhinorrhea, and itching. Montelukast is a selective leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor, which helps to reduce airway edema, smooth muscle contraction, and inflammation. The syrup is specifically indicated for the treatment of seasonal and perennial allergic rhinitis, chronic idiopathic urticaria, and as an add-on therapy for mild to moderate persistent asthma in patients aged 15 years and older.

Brand names
L-Zinex DuoL-ZINEX DUO Syrup
Other names
levocetirizine + montelukast
02

Targets

CYSLTR1 (Cysteinyl-leukotriene type 1 receptor)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on L-Zinex Duo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-Zinex Duo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call